Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Multicenter, Open, Prospective, Controlled Study-comparison of the Safety of Immediate One-stage Implant Based Breast Reconstruction(IBBR) Versus Two-stage Expander-Implant IBBR Augmented With TiLoop® Bra.

NCT03589924 is registered in ClinicalTrials.gov with Jiong Wu as lead sponsor.

NCT NCT03589924
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03589924 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Multicenter, Open, Prospective, Controlled Study-comparison of the Safety of Immediate One-stage Implant Based Breast Reconstruction(IBBR) Versus Two-stage Expander-Implant IBBR Augmented With TiLoop® Bra.
Lead sponsor
Jiong Wu
Phase
Not applicable
Overall status
Unknown status
Start date
June 1, 2018
Completion date
September 30, 2024
Enrollment
440 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer